Misato Ito
Impact in
-
- Cytokine Signaling Pathways and Interactions
- Cancer Immunotherapy and Biomarkers
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies
Papers in
- Oncology 14
- Cytokine Signaling Pathways and Interactions 5
- Cancer Immunotherapy and Biomarkers 4
- Chemokine receptors and signaling 3
- Colorectal Cancer Treatments and Studies 2
-
- Radical Photochemical Reactions 4
- Co-authors
- Shohei Shirakami (5 shared papers)Yasuyuki Higashi (3 shared papers)Takayuki Inoue (4 shared papers)Masamichi Inami (5 shared papers)Koji Nakamura (5 shared papers)Masahiro Murakami (5 shared papers)Yutaka Nakajima (3 shared papers)Ayako Moritomo (3 shared papers)
- Journals
- Anticancer Research (3 papers)Cancer Immunology Immunotherapy (3 papers)Chemistry Letters (3 papers)Bioorganic & Medicinal Chemistry (3 papers)International Immunopharmacology (2 papers)
- Partner nations
- JapanUnited Kingdom
In The Last Decade
Misato Ito
36 papers receiving 366 citations
Peers
Comparison fields: 5 of 59
- Oncology 147
- Rheumatology 72
- Genetics 43
- Immunology 77
- Hematology 27
Countries citing papers authored by Misato Ito
This map shows the geographic impact of Misato Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Misato Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Misato Ito more than expected).
Fields of papers citing papers by Misato Ito
This network shows the impact of papers produced by Misato Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Misato Ito. The network helps show where Misato Ito may publish in the future.
Co-authors
The 25 scholars most cited alongside Misato Ito, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 78 | |
| 2 | 2018 | 67 | |
| 3 | 2022 | 25 | |
| 4 | 2020 | 17 | |
| 5 | 2002 | 16 | |
| 6 | 2022 | 13 | |
| 7 | 2023 | 11 | |
| 8 | 2016 | 11 | |
| 9 | 2021 | 10 | |
| 10 | 2021 | 10 | |
| 11 | 2020 | 9 | |
| 12 | 2021 | 9 | |
| 13 | 2016 | 8 | |
| 14 | 2009 | 7 | |
| 15 | 2017 | 7 | |
| 16 | 2020 | 7 | |
| 17 | 2021 | 6 | |
| 18 | 2021 | 6 | |
| 19 | 2020 | 6 | |
| 20 | 2019 | 5 |
About Misato Ito
Misato Ito is a scholar working on Oncology, Organic Chemistry, Immunology, Molecular Biology and Rheumatology, having authored 38 papers that have together received 374 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Radical Photochemical Reactions (4 papers), Immune Cell Function and Interaction (3 papers), Chemokine receptors and signaling (3 papers), Renal Transplantation Outcomes and Treatments (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Systemic Lupus Erythematosus Research (2 papers). The work is most often cited by research in Oncology (147 citations), Rheumatology (72 citations), Genetics (43 citations), Immunology (77 citations) and Hematology (27 citations). Misato Ito has collaborated with scholars based in Japan and United Kingdom. Frequent co-authors include Shohei Shirakami, Yasuyuki Higashi, Takayuki Inoue, Masamichi Inami, Koji Nakamura, Masahiro Murakami, Yutaka Nakajima, Ayako Moritomo, Yoshiaki Morita and Masako Kuno. Their work appears in journals such as Anticancer Research, Cancer Immunology Immunotherapy, Chemistry Letters, Bioorganic & Medicinal Chemistry and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.